Phase II study of fotemustine in advanced soft tissue sarcomas. A trial of the EORTC Soft Tissue and Bone Sarcoma Group

Eur J Cancer. 1992;29A(1):143-4. doi: 10.1016/0959-8049(93)90594-6.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Male
  • Middle Aged
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Organophosphorus Compounds / adverse effects
  • Organophosphorus Compounds / therapeutic use*
  • Sarcoma / drug therapy*
  • Soft Tissue Neoplasms / drug therapy*
  • Thrombocytopenia / chemically induced

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine